Myomo is a wearable medical robotics company that develops and markets the MyoPro product line—custom-fabricated upper limb orthoses (braces) designed to help patients with neuromuscular disorders and paralysis regain functional arm movement. The devices use patented non-invasive electromyography sensors and advanced signal processing to detect weak muscle signals that indicate a user's intention to move, enabling self-initiated control without electrical stimulation. Myomo generates revenue through multiple channels: direct billing to insurance companies for custom-fitted devices, wholesale distribution to orthotics and prosthetics providers, sales to the Veterans Administration, and international partnerships. The target market comprises millions of patients with conditions including stroke, spinal cord injury, traumatic brain injury, and peripheral nerve injuries, with the company receiving reimbursement from Medicare and other payers on a per-device basis.